Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatology

J S Dover1, K A Arndt

  • 1New England Deaconess Hospital and Harvard Medical School, Boston, Mass., USA.

JAMA
|June 7, 1995
PubMed
Summary
This summary is machine-generated.

Calcipotriene ointment is now approved for moderate plaque psoriasis. New laser treatments are effective for pigmented skin disorders, and novel systemic fungicides target nail fungus (tinea unguium).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Note.

Archives of dermatology·2014
Same author

Use of cutaneous lasers and light sources: appropriate training and delegation.

Skin therapy letter·2007
Same author

Treatment of acne scarring.

Skin therapy letter·2006
Same author

Fractional Laser treatment for pigmentation and texture improvement.

Skin therapy letter·2006
Same author

The use of lasers for decorative tattoo removal.

Skin therapy letter·2006
Same author

The use of lasers in the pediatric population.

Skin therapy letter·2005
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Area of Science:

  • Dermatology and Cutaneous Medicine
  • Pharmacological Innovations
  • Laser and Light-Based Therapies

Background:

  • Psoriasis treatment landscape evolving with new topical agents.
  • Advancements in dermatological laser technology offer new therapeutic options.
  • Fungal infections of the nail (tinea unguium) present ongoing treatment challenges.

Purpose of the Study:

  • To highlight recent advancements in dermatological treatments.
  • To review the efficacy of new therapeutic modalities for skin conditions.
  • To inform clinicians about emerging options for psoriasis, pigmented lesions, and onychomycosis.

Main Methods:

  • Review of recent FDA approvals and clinical trial data for Calcipotriene ointment.
  • Analysis of emerging laser and light-based treatment protocols for cutaneous pigmented disorders.

Related Experiment Videos

  • Examination of clinical studies on newly developed systemic fungicidal drugs for tinea unguium.

    • Main Results:

    • Calcipotriene ointment demonstrates efficacy in managing moderate plaque psoriasis.
    • Laser therapies show promise for treating various cutaneous pigmented disorders effectively.
    • New systemic antifungal agents provide effective treatment options for onychomycosis.

    Conclusions:

    • Calcipotriene ointment offers a new therapeutic avenue for plaque psoriasis.
    • Laser technology represents a significant advancement in treating pigmented skin conditions.
    • Novel systemic fungicides expand the therapeutic armamentarium for tinea unguium.